SAROJA

Saroja Pharma Industries India Share Price

₹57.95 +4.95 (9.34%)

22 Nov, 2024 03:10

SIP TrendupStart SIP in SAROJA

Start SIP

Performance

  • Low
  • ₹58
  • High
  • ₹58
  • 52 Week Low
  • ₹33
  • 52 Week High
  • ₹71
  • Open Price₹58
  • Previous Close₹53
  • Volume1,600

Investment Returns

  • Over 1 Month -4.61%
  • Over 3 Month + 22%
  • Over 6 Month + 23.3%
  • Over 1 Year -3.42%
SIP Lightning

Smart Investing Starts Here Start SIP with Saroja Pharma Industries India for Steady Growth!

Invest Now

Saroja Pharma Industries India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 23
  • P/B Ratio
  • 1.6
  • Average True Range
  • 2.24
  • EPS
  • 2.18
  • Dividend Yield
  • 0
  • MACD Signal
  • -0
  • RSI
  • 52.73
  • MFI
  • 32.93

Saroja Pharma Industries India Financials

Saroja Pharma Industries India Technicals

EMA & SMA

Current Price
₹57.95
+ 4.95 (9.34%)
pointer
  • stock-down_img
  • Bullish Moving Average 15
  • stock-up_img
  • Bearish Moving Average 1
  • 20 Day
  • ₹56.59
  • 50 Day
  • ₹55.06
  • 100 Day
  • ₹52.80
  • 200 Day
  • ₹52.49

Resistance and Support

57.95 Pivot Speed
  • R3 57.95
  • R2 57.95
  • R1 57.95
  • S1 57.95
  • S2 57.95
  • S3 57.95

What's your outlook on Saroja Pharma Industries India?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Saroja Pharma Industries India Ltd has an operating revenue of Rs. 183.16 Cr. on a trailing 12-month basis. An annual revenue de-growth of -19% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Saroja Pharma Industries India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-05-29 Audited Results

Saroja Pharma Industries India F&O

Saroja Pharma Industries India Shareholding Pattern

73.02%
24.04%
2.94%

About Saroja Pharma Industries India

  • NSE Symbol
  • SAROJA
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Biju Gopinathan Nair
  • ISIN
  • INE0PCL01011

Similar Stocks to Saroja Pharma Industries India

Saroja Pharma Industries India FAQs

Saroja Pharma Industries India share price is ₹57 As on 22 November, 2024 | 02:56

The Market Cap of Saroja Pharma Industries India is ₹23.3 Cr As on 22 November, 2024 | 02:56

The P/E ratio of Saroja Pharma Industries India is As on 22 November, 2024 | 02:56

The PB ratio of Saroja Pharma Industries India is 1.6 As on 22 November, 2024 | 02:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23